PROCEDIMIENTO DE OBTENCION DE UNA COMPOSICION FARMACEUTICA A BASE DE INMUNOGLOBULINA Y FIBRONECTINA.

摘要

There is disclosed a pharmaceutical composition for therapeutic use comprising an immune globulin and fibronectin in amounts sufficient to produce an opsonic activity in the composition that is greater than the additive opsonic activity of the individual agents or in amounts sufficient to produce a phagocytosis of infectious agents greater than the additive effect from fibronectin and immune globulin alone.